Buscemi N, Vandermeer B, Pandya R, Hooton N, Tjosvold L, Hartling L, Baker G, Vohra S, Klassen T (2004年11月). “Melatonin for treatment of sleep disorders”. Evidence Report/Technology Assessment No. 108. (Prepared by the University of Alberta Evidence-based Practice Center, under Contract No. 290-02-0023.) AHRQ Publication No. 05-E002-2. Rockville, MD: Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services. 2013年6月5日閲覧。
Caniato R, Filippini R, Piovan A, Puricelli L, Borsarini A, Cappelletti EM (2003). “Melatonin in plants”. Adv. Exp. Med. Biol.. Advances in Experimental Medicine and Biology 527: 593–7. doi:10.1007/978-1-4615-0135-0_68. ISBN978-0-306-47755-3. PMID15206778.
Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ (2009). “Phytomelatonin: a review”. J. Exp. Bot.60 (1): 57–69. doi:10.1093/jxb/ern284. PMID19033551.
Boutin JA, Audinot V, Ferry G, Delagrange P (August 2005). “Molecular tools to study melatonin pathways and actions”. Trends Pharmacol. Sci.26 (8): 412–9. doi:10.1016/j.tips.2005.06.006. PMID15992934.
Hardeland R (July 2005). “Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance”. Endocrine27 (2): 119–30. doi:10.1385/ENDO:27:2:119. PMID16217125.
Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S; Acuña-Castroviejo; Tan; Burkhardt (June 2001). “Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system”. Ann. N. Y. Acad. Sci.939: 200–15. Bibcode: 2001NYASA.939..200R. doi:10.1111/j.1749-6632.2001.tb03627.x. PMID11462772.
Reiter RJ (May 1991). “Pineal melatonin: cell biology of its synthesis and of its physiological interactions”. Endocr. Rev.12 (2): 151–80. doi:10.1210/edrv-12-2-151. PMID1649044.
Perreau-Lenz S, Pévet P, Buijs RM, Kalsbeek A (January 2004). “The biological clock: the bodyguard of temporal homeostasis”. Chronobiol. Int.21 (1): 1–25. doi:10.1081/CBI-120027984. PMID15129821.
Ardura J, Gutierrez R, Andres J, Agapito T (2003). “Emergence and evolution of the circadian rhythm of melatonin in children”. Horm. Res.59 (2): 66–72. doi:10.1159/000068571. PMID12589109.
Kayumov L, Casper RF, Hawa RJ, Perelman B, Chung SA, Sokalsky S, Shapiro CM (May 2005). “Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work”. J. Clin. Endocrinol. Metab.90 (5): 2755–61. doi:10.1210/jc.2004-2062. PMID15713707.
Burkhart K, Phelps JR. (26 December 2009). “Amber lenses to block blue light and improve sleep: a randomized trial”. Chronobiol Int26 (8): 1602–12. doi:10.3109/07420520903523719. PMID20030543.
Vecchierini MF, Kilic-Huck U, Quera-Salva MA (2021-3). “Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS)”. Rev Neurol (Paris)177 (3): 245–259. doi:10.1016/j.neurol.2020.06.009. PMID32921425.
Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S; Acuña-Castroviejo; Tan; Burkhardt (June 2001). “Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system”. Ann. N. Y. Acad. Sci.939: 200–15. Bibcode: 2001NYASA.939..200R. doi:10.1111/j.1749-6632.2001.tb03627.x. PMID11462772.
Gavin ML, Scaivina MT (March 2013 2009). “Why Aren't Teens Getting Enough Sleep?” (英語). How Much Sleep Do I Need?. The Nemours Foundation. 2017年2月10日閲覧。
nih.gov
pubmed.ncbi.nlm.nih.gov
Caniato R, Filippini R, Piovan A, Puricelli L, Borsarini A, Cappelletti EM (2003). “Melatonin in plants”. Adv. Exp. Med. Biol.. Advances in Experimental Medicine and Biology 527: 593–7. doi:10.1007/978-1-4615-0135-0_68. ISBN978-0-306-47755-3. PMID15206778.
Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ (2009). “Phytomelatonin: a review”. J. Exp. Bot.60 (1): 57–69. doi:10.1093/jxb/ern284. PMID19033551.
Boutin JA, Audinot V, Ferry G, Delagrange P (August 2005). “Molecular tools to study melatonin pathways and actions”. Trends Pharmacol. Sci.26 (8): 412–9. doi:10.1016/j.tips.2005.06.006. PMID15992934.
Hardeland R (July 2005). “Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance”. Endocrine27 (2): 119–30. doi:10.1385/ENDO:27:2:119. PMID16217125.
Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S; Acuña-Castroviejo; Tan; Burkhardt (June 2001). “Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system”. Ann. N. Y. Acad. Sci.939: 200–15. Bibcode: 2001NYASA.939..200R. doi:10.1111/j.1749-6632.2001.tb03627.x. PMID11462772.
Reiter RJ (May 1991). “Pineal melatonin: cell biology of its synthesis and of its physiological interactions”. Endocr. Rev.12 (2): 151–80. doi:10.1210/edrv-12-2-151. PMID1649044.
Richardson GS (2005). “The human circadian system in normal and disordered sleep”. J Clin Psychiatry66 Suppl 9: 3–9; quiz 42–3. PMID16336035.
Perreau-Lenz S, Pévet P, Buijs RM, Kalsbeek A (January 2004). “The biological clock: the bodyguard of temporal homeostasis”. Chronobiol. Int.21 (1): 1–25. doi:10.1081/CBI-120027984. PMID15129821.
Ardura J, Gutierrez R, Andres J, Agapito T (2003). “Emergence and evolution of the circadian rhythm of melatonin in children”. Horm. Res.59 (2): 66–72. doi:10.1159/000068571. PMID12589109.
Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD (August 2001). “Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor”. J. Neurosci.21 (16): 6405–12. PMID11487664.
Kayumov L, Casper RF, Hawa RJ, Perelman B, Chung SA, Sokalsky S, Shapiro CM (May 2005). “Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work”. J. Clin. Endocrinol. Metab.90 (5): 2755–61. doi:10.1210/jc.2004-2062. PMID15713707.
Burkhart K, Phelps JR. (26 December 2009). “Amber lenses to block blue light and improve sleep: a randomized trial”. Chronobiol Int26 (8): 1602–12. doi:10.3109/07420520903523719. PMID20030543.
Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC (October 2005). “Phase-dependent treatment of delayed sleep phase syndrome with melatonin”. Sleep28 (10): 1271–8. PMID16295212.
Vecchierini MF, Kilic-Huck U, Quera-Salva MA (2021-3). “Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS)”. Rev Neurol (Paris)177 (3): 245–259. doi:10.1016/j.neurol.2020.06.009. PMID32921425.